Molecule intelOpportunity: Lower0

Cimetidine

78 brands · 69 companies · product forms

Opportunity snapshot

Launch attractiveness
11
Market saturation
86
Price room
33
Regulatory risk
0
78
brands
69
companies
Rs 332.7
median price
7
price points
2.33x
price spread
90
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 4%

Price room

Across observed sources and strengths
CheapestRs 157.3
MedianRs 332.7
Most expensiveRs 366.66
Spread2.33×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 2.33x across 7 trusted points (Rs 157.3-366.66). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 9 live products for Cimetidine — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(0) + 25% price-variation(33) + 20% low-competition(14) + 15% supply-disruption(0), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

69 canonical companies and 78 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 2.33x across 7 trusted points (Rs 157.3-366.66). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Reduced by: no ATC code.

Packaged brief for this lower opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.